Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney S Graham

Showing results (21-30 of 420) with videos related to

Pageof 42
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infectionJohn A Rutigliano, Barney S Graham
The Journal of Infectious Diseases|December 22, 2017
Zika Virus Vaccine DevelopmentKaitlyn M Morabito, Barney S Graham
Journal of Virology|January 15, 2003
Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formationLewis H McCurdy, Barney S Graham
Nature Immunology|December 5, 2017
Emerging viral diseases from a vaccinology perspective: preparing for the next pandemicBarney S Graham, Nancy J Sullivan
The Pediatric Infectious Disease Journal|January 20, 2004
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infectionTeresa R Johnson, Barney S Graham
The Journal of Antimicrobial Chemotherapy|July 16, 2004
Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding virusesPhilip J Budge, Barney S Graham
Journal of Virology|October 12, 2007
Viral and host factors in human respiratory syncytial virus pathogenesisPeter L Collins, Barney S Graham
Proceedings of the American Thoracic Society|August 23, 2005
Pathogenesis of respiratory syncytial virus infection in the murine modelR Stokes Peebles, Barney S Graham
The Journal of Clinical Investigation|May 1, 2020
Prototype pathogen approach for pandemic preparedness: world on fireBarney S Graham, Kizzmekia S Corbett
Current Opinion in HIV and AIDS|March 12, 2015
History of passive antibody administration for prevention and treatment of infectious diseasesBarney S Graham, Donna M Ambrosino
Pageof 42

Showing results (21-30 of 420) with videos related to

Sort By:
Pageof 42
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infectionJohn A Rutigliano, Barney S Graham
The Journal of Infectious Diseases|December 22, 2017
Zika Virus Vaccine DevelopmentKaitlyn M Morabito, Barney S Graham
Journal of Virology|January 15, 2003
Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formationLewis H McCurdy, Barney S Graham
Nature Immunology|December 5, 2017
Emerging viral diseases from a vaccinology perspective: preparing for the next pandemicBarney S Graham, Nancy J Sullivan
The Pediatric Infectious Disease Journal|January 20, 2004
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infectionTeresa R Johnson, Barney S Graham
The Journal of Antimicrobial Chemotherapy|July 16, 2004
Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding virusesPhilip J Budge, Barney S Graham
Journal of Virology|October 12, 2007
Viral and host factors in human respiratory syncytial virus pathogenesisPeter L Collins, Barney S Graham
Proceedings of the American Thoracic Society|August 23, 2005
Pathogenesis of respiratory syncytial virus infection in the murine modelR Stokes Peebles, Barney S Graham
The Journal of Clinical Investigation|May 1, 2020
Prototype pathogen approach for pandemic preparedness: world on fireBarney S Graham, Kizzmekia S Corbett
Current Opinion in HIV and AIDS|March 12, 2015
History of passive antibody administration for prevention and treatment of infectious diseasesBarney S Graham, Donna M Ambrosino
Pageof 42